ID SIG11_HUMAN Reviewed; 698 AA. AC Q96RL6; DT 08-NOV-2002, integrated into UniProtKB/Swiss-Prot. DT 20-APR-2010, sequence version 2. DT 27-MAR-2024, entry version 184. DE RecName: Full=Sialic acid-binding Ig-like lectin 11; DE Short=Sialic acid-binding lectin 11; DE Short=Siglec-11; DE Flags: Precursor; GN Name=SIGLEC11; ORFNames=UNQ9222/PRO28718; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INTERACTION WITH PTPN6 AND RP PTPN11. RX PubMed=11986327; DOI=10.1074/jbc.m202833200; RA Angata T., Kerr S.C., Greaves D.R., Varki N.M., Crocker P.R., Varki A.; RT "Cloning and characterization of human Siglec-11. A recently evolved RT signaling molecule that can interact with SHP-1 and SHP-2 and is expressed RT by tissue macrophages, including brain microglia."; RL J. Biol. Chem. 277:24466-24474(2002). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15057824; DOI=10.1038/nature02399; RA Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E., RA Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A., RA Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S., RA Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A., RA Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J., RA Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M., RA Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W., RA Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V., RA Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D., RA McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I., RA Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L., RA Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., RA She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., RA Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., RA Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E., RA Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M., RA Rubin E.M., Lucas S.M.; RT "The DNA sequence and biology of human chromosome 19."; RL Nature 428:529-535(2004). RN [3] RP PARTIAL NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RX PubMed=12975309; DOI=10.1101/gr.1293003; RA Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., RA Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., RA Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A., RA Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D., RA Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L., RA Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C., RA Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J., RA Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.; RT "The secreted protein discovery initiative (SPDI), a large-scale effort to RT identify novel human secreted and transmembrane proteins: a bioinformatics RT assessment."; RL Genome Res. 13:2265-2270(2003). CC -!- FUNCTION: Putative adhesion molecule that mediates sialic-acid CC dependent binding to cells. Preferentially binds to alpha-2,8-linked CC sialic acid. The sialic acid recognition site may be masked by cis CC interactions with sialic acids on the same cell surface. In the immune CC response, may act as an inhibitory receptor upon ligand induced CC tyrosine phosphorylation by recruiting cytoplasmic phosphatase(s) via CC their SH2 domain(s) that block signal transduction through CC dephosphorylation of signaling molecules. CC -!- SUBUNIT: Interacts with PTPN6/SHP-1 and PTPN11/SHP-2 upon CC phosphorylation. {ECO:0000269|PubMed:11986327}. CC -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q96RL6-1; Sequence=Displayed; CC Name=2; CC IsoId=Q96RL6-2; Sequence=VSP_008764; CC -!- TISSUE SPECIFICITY: Expressed by macrophages in various tissues CC including Kupffer cells. Also found in brain microglia. CC -!- DOMAIN: Contains 1 copy of a cytoplasmic motif that is referred to as CC the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is CC involved in modulation of cellular responses. The phosphorylated ITIM CC motif can bind the SH2 domain of several SH2-containing phosphatases. CC -!- PTM: Phosphorylated on tyrosine residues. CC -!- SIMILARITY: Belongs to the immunoglobulin superfamily. SIGLEC (sialic CC acid binding Ig-like lectin) family. {ECO:0000305}. CC -!- CAUTION: It is uncertain whether Met-1 or Met-13 is the initiator. CC {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAK72907.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC Sequence=AAQ88502.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF337818; AAK72907.1; ALT_INIT; mRNA. DR EMBL; AC011452; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AY358135; AAQ88502.1; ALT_INIT; mRNA. DR CCDS; CCDS12790.2; -. [Q96RL6-1] DR CCDS; CCDS46150.1; -. [Q96RL6-2] DR RefSeq; NP_001128635.1; NM_001135163.1. [Q96RL6-2] DR RefSeq; NP_443116.2; NM_052884.2. [Q96RL6-1] DR AlphaFoldDB; Q96RL6; -. DR SMR; Q96RL6; -. DR BioGRID; 125285; 5. DR IntAct; Q96RL6; 8. DR STRING; 9606.ENSP00000412361; -. DR GlyCosmos; Q96RL6; 7 sites, No reported glycans. DR GlyGen; Q96RL6; 8 sites. DR iPTMnet; Q96RL6; -. DR PhosphoSitePlus; Q96RL6; -. DR SwissPalm; Q96RL6; -. DR BioMuta; SIGLEC11; -. DR DMDM; 294862467; -. DR MassIVE; Q96RL6; -. DR PaxDb; 9606-ENSP00000412361; -. DR PeptideAtlas; Q96RL6; -. DR ProteomicsDB; 77982; -. [Q96RL6-1] DR ProteomicsDB; 77983; -. [Q96RL6-2] DR Antibodypedia; 32226; 237 antibodies from 30 providers. DR DNASU; 114132; -. DR Ensembl; ENST00000426971.2; ENSP00000398891.2; ENSG00000161640.15. [Q96RL6-2] DR Ensembl; ENST00000447370.6; ENSP00000412361.2; ENSG00000161640.15. [Q96RL6-1] DR GeneID; 114132; -. DR KEGG; hsa:114132; -. DR MANE-Select; ENST00000447370.6; ENSP00000412361.2; NM_052884.3; NP_443116.2. DR UCSC; uc010ybh.3; human. [Q96RL6-1] DR AGR; HGNC:15622; -. DR CTD; 114132; -. DR GeneCards; SIGLEC11; -. DR HGNC; HGNC:15622; SIGLEC11. DR HPA; ENSG00000161640; Group enriched (lymphoid tissue, ovary). DR MIM; 607157; gene. DR neXtProt; NX_Q96RL6; -. DR OpenTargets; ENSG00000161640; -. DR PharmGKB; PA38005; -. DR VEuPathDB; HostDB:ENSG00000161640; -. DR eggNOG; ENOG502S41V; Eukaryota. DR GeneTree; ENSGT01080000257333; -. DR HOGENOM; CLU_024444_5_1_1; -. DR InParanoid; Q96RL6; -. DR OMA; DCSLMIR; -. DR OrthoDB; 2963061at2759; -. DR PhylomeDB; Q96RL6; -. DR TreeFam; TF332441; -. DR PathwayCommons; Q96RL6; -. DR Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell. DR SignaLink; Q96RL6; -. DR BioGRID-ORCS; 114132; 68 hits in 1142 CRISPR screens. DR GenomeRNAi; 114132; -. DR Pharos; Q96RL6; Tbio. DR PRO; PR:Q96RL6; -. DR Proteomes; UP000005640; Chromosome 19. DR RNAct; Q96RL6; Protein. DR Bgee; ENSG00000161640; Expressed in adrenal tissue and 107 other cell types or tissues. DR ExpressionAtlas; Q96RL6; baseline and differential. DR GO; GO:0005886; C:plasma membrane; IBA:GO_Central. DR GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW. DR GO; GO:0019902; F:phosphatase binding; IPI:UniProtKB. DR GO; GO:0033691; F:sialic acid binding; IDA:UniProtKB. DR GO; GO:0007155; P:cell adhesion; IBA:GO_Central. DR CDD; cd20987; IgC2_CD33_d2_like; 1. DR CDD; cd05712; IgV_CD33; 1. DR Gene3D; 2.60.40.10; Immunoglobulins; 4. DR InterPro; IPR007110; Ig-like_dom. DR InterPro; IPR036179; Ig-like_dom_sf. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003006; Ig/MHC_CS. DR InterPro; IPR013098; Ig_I-set. DR InterPro; IPR003599; Ig_sub. DR InterPro; IPR003598; Ig_sub2. DR InterPro; IPR013106; Ig_V-set. DR PANTHER; PTHR12035; SIALIC ACID BINDING IMMUNOGLOBULIN-LIKE LECTIN; 1. DR PANTHER; PTHR12035:SF96; SIALIC ACID-BINDING IG-LIKE LECTIN 16; 1. DR Pfam; PF07679; I-set; 1. DR Pfam; PF13927; Ig_3; 1. DR Pfam; PF07686; V-set; 1. DR SMART; SM00409; IG; 4. DR SMART; SM00408; IGc2; 2. DR SUPFAM; SSF48726; Immunoglobulin; 5. DR PROSITE; PS50835; IG_LIKE; 3. DR PROSITE; PS00290; IG_MHC; 1. DR Genevisible; Q96RL6; HS. PE 1: Evidence at protein level; KW Alternative splicing; Cell adhesion; Disulfide bond; Glycoprotein; KW Immunoglobulin domain; Lectin; Membrane; Phosphoprotein; KW Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix. FT SIGNAL 1..27 FT /evidence="ECO:0000255" FT CHAIN 28..698 FT /note="Sialic acid-binding Ig-like lectin 11" FT /id="PRO_0000014951" FT TOPO_DOM 28..561 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 562..584 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 585..698 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 31..134 FT /note="Ig-like V-type" FT DOMAIN 159..244 FT /note="Ig-like C2-type 1" FT DOMAIN 251..350 FT /note="Ig-like C2-type 2" FT DOMAIN 355..452 FT /note="Ig-like C2-type 3" FT REGION 596..635 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 675..698 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 642..647 FT /note="ITIM motif" FT COMPBIAS 603..627 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 132 FT /ligand="N-acetylneuraminate" FT /ligand_id="ChEBI:CHEBI:35418" FT /evidence="ECO:0000250" FT MOD_RES 668 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:Q96LC7" FT CARBOHYD 55 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 90 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 262 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 366 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 375 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 497 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 515 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 49..186 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114" FT DISULFID 54..114 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114" FT DISULFID 177..228 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114" FT DISULFID 287..334 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114" FT DISULFID 391..436 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114" FT VAR_SEQ 455..551 FT /note="YPPQLLGPSCSWEAEGLHCSCSSQASPAPSLRWWLGEELLEGNSSQGSFEVT FT PSSAGPWANSSLSLHGGLSSGLRLRCKAWNVHGAQSGSVFQLLPG -> W (in FT isoform 2)" FT /evidence="ECO:0000305" FT /id="VSP_008764" FT CONFLICT 96 FT /note="E -> A (in Ref. 3; AAQ88502)" FT /evidence="ECO:0000305" FT CONFLICT 365 FT /note="A -> G (in Ref. 3; AAQ88502)" FT /evidence="ECO:0000305" SQ SEQUENCE 698 AA; 75795 MW; 61CF0F530DCDD62F CRC64; MVPGQAQPQS PEMLLLPLLL PVLGAGSLNK DPSYSLQVQR QVPVPEGLCV IVSCNLSYPR DGWDESTAAY GYWFKGRTSP KTGAPVATNN QSREVEMSTR DRFQLTGDPG KGSCSLVIRD AQREDEAWYF FRVERGSRVR HSFLSNAFFL KVTALTKKPD VYIPETLEPG QPVTVICVFN WAFKKCPAPS FSWTGAALSP RRTRPSTSHF SVLSFTPSPQ DHDTDLTCHV DFSRKGVSAQ RTVRLRVAYA PKDLIISISH DNTSALELQG NVIYLEVQKG QFLRLLCAAD SQPPATLSWV LQDRVLSSSH PWGPRTLGLE LRGVRAGDSG RYTCRAENRL GSQQQALDLS VQYPPENLRV MVSQANRTVL ENLGNGTSLP VLEGQSLRLV CVTHSSPPAR LSWTRWGQTV GPSQPSDPGV LELPPIQMEH EGEFTCHAQH PLGSQHVSLS LSVHYPPQLL GPSCSWEAEG LHCSCSSQAS PAPSLRWWLG EELLEGNSSQ GSFEVTPSSA GPWANSSLSL HGGLSSGLRL RCKAWNVHGA QSGSVFQLLP GKLEHGGGLG LGAALGAGVA ALLAFCSCLV VFRVKICRKE ARKRAAAEQD VPSTLGPISQ GHQHECSAGS SQDHPPPGAA TYTPGKGEEQ ELHYASLSFQ GLRLWEPADQ EAPSTTEYSE IKIHTGQPLR GPGFGLQLER EMSGMVPK //